Calumet, Inc. (CLMT) exhibits a fragile profitability profile, with all three margin metrics clustered near the lower end of their historical distributions. The gross margin sits at 5.9%, well below its 10‑year average of 9.4% and in the 16th percentile, indicating limited pricing power or elevated cost structure relative to peers over the past decade. While operating and net margins are modestly better positioned—operating margin at 1.3% (47th percentile) and net margin at -0.8% (81st percentile)—the net margin remains negative, triggering a critical alert. The overall picture suggests that earnings are highly sensitive to cost fluctuations and any adverse market shifts could quickly erode the thin profit buffer.

Calumet, Inc. (CLMT) presents a mixed picture on leverage and solvency. The debt-to-equity ratio has moved from a historically low -3.01x average to a current -0.52x, indicating a reduction in net equity exposure but also reflecting the company’s negative equity position; the 55th percentile placement suggests it is near the median of its ten‑year distribution, yet the YoY increase of +2.81 points signals deteriorating balance‑sheet strength. Net debt relative to EBITDA stands at 1.1x, far below the ten‑year average of 13.0x and comfortably under typical covenant thresholds (often set around 3.0x), placing the company in the lower third (32nd percentile) of its historical range, which is a positive indicator of cash‑flow coverage.

Calumet, Inc. demonstrates modest but stable cash generation capabilities. Operating cash flow matches its 10‑year average at $0.1 billion and shows a robust year‑over‑year increase of $155.3 million, indicating that the core business continues to convert earnings into cash without significant volatility. Free cash flow has turned positive, moving from a 10‑year average deficit of $-0.1 billion to a current surplus of $0.1 billion and improving by $179.7 million YoY, suggesting better capital expenditure discipline and an emerging capacity to fund growth or debt repayment. Liquidity metrics are narrowly above the minimum safety thresholds. The current ratio has risen to 1.02× from a decade‑average of 1.00×, reflecting a slight improvement in short‑term asset coverage of liabilities. The quick ratio, at 0.56× versus a 10‑year average of 0.50×, and the cash ratio, now 0.15× up from 0.10×, both indicate incremental progress but remain below the conventional 1.0× benchmark for comfortable liquidity. Overall, cash flow generation is adequate, while liquidity remains tight yet improving.

Calumet's earnings quality is markedly weak, as evidenced by an operating cash flow to net income ratio of -3.22x, far below the acceptable threshold of 0.8x. This indicates that the company’s reported profit is not supported by cash generation and, in fact, operating cash flow is negative relative to net income. The accrual ratio of -5.3% suggests modest earnings manipulation, but it remains less adverse than the ten‑year average, signaling that a portion of earnings still diverges from cash flow. Stock‑based compensation is minimal at 0.1% of revenue, an improvement over its historical 0.3%, reducing dilution risk. However, capital intensity has deteriorated sharply: CapEx now consumes 48% of operating cash flow versus a historic average of 163%, and the year‑over‑year increase of 213% signals rising pressure on free cash generation.